|Bid||1,503.50 x 175400|
|Ask||1,504.00 x 417900|
|Day's Range||1,497.00 - 1,509.50|
|52 Week Range||1,446.50 - 1,745.56|
|PE Ratio (TTM)||44.09|
|Earnings Date||Oct 25, 2017|
|Dividend & Yield||1.01 (5.15%)|
|1y Target Est||1,743.04|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GlaxoSmithKline Plc Here are 5 ETFs with the largest exposure to GSK-GB. Comparing the performance and risk of GlaxoSmithKline Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
The drug would be the first such treatment in Europe.
Barely four months into her tenure as chief executive of GlaxoSmithKline, Emma Walmsley is showing her determination to focus the pharmaceutical company's research and development efforts. Having said ...